The US Patent and Trademark Office is extending two pilot programs for prioritizing examination of patents related to Covid-19 and cancer therapies, the office announced Tuesday.
The programs have expedited consideration of hundreds of patents, with more than 260 Covid-19-related patents and more than 600 cancer patents issued under the programs, according to the PTO.
The PTO said in a Federal Register notice that it would continue to accept, through Dec. 31, requests to expedite consideration of patent applications regarding innovations to combat the coronavirus pandemic under its Modified Covid-19 Prioritized Examination Pilot Program.
It’s the latest in a series ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.